Aradigm

About:

Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.

Website: http://www.aradigm.com/

Top Investors: New Enterprise Associates, Domain Associates, Camden Partners, Castle Creek Partners

Description:

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and smoking cessation.